PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J 3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,458,952 | Method and system for harvesting micro organisms | Jun 10, 11 | Jun 11, 13 | INDEPENDENCE BIO-PRODUCTS, INC. |
| 8,459,046 | Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product | Nov 12, 10 | Jun 11, 13 | ALK-ABELLO A/S |
| 8,460,635 | Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents | Mar 11, 09 | Jun 11, 13 | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY |
| 8,460,640 | Narcotic drug formulations with decreased abuse potential | Dec 14, 09 | Jun 11, 13 | PALADIN LABS, INC. |
| 8,460,641 | Microemulsion process and composition | Aug 31, 05 | Jun 11, 13 | STIEFEL RESEARCH AUSTRALIA PTY LTD. |
| 8,460,642 | Boldline compounds for promoting bone growth | Apr 25, 12 | Jun 11, 13 | OSSIFI, INC. |
| 8,460,643 | Formulation for prophylaxis of oral cavity diseases | Nov 25, 05 | Jun 11, 13 | OBSCHESTVO S ORGANICHENNOI OTVETSTVENNOSTYU “WDS” |
| 8,460,644 | Synergistic mixed poloxamer systems for the solubilisation of drugs | Jun 04, 10 | Jun 11, 13 | IS PHARMACEUTICALS LIMITED |
| 8,460,646 | Methods and compositions for treating mammalian nerve tissue injuries | Jul 23, 09 | Jun 11, 13 | PURDUE RESEARCH FOUNDATION |
| 8,460,648 | Probiotic recolonisation therapy | Jul 25, 01 | Jun 11, 13 | Not available |
| 8,460,652 | Topical skin care formulations | Sep 21, 12 | Jun 11, 13 | Not available |
| 8,460,653 | Superoxide dismutase variants and methods of use thereof | Sep 20, 11 | Jun 11, 13 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 8,460,654 | Use of alkaline phosphatase to maintain healthy tissue mass in mammals | Mar 02, 10 | Jun 11, 13 | ZOLTAN LABORATORIES LLC |
| 8,460,655 | Pharmacological vitreolysis | Jun 05, 08 | Jun 11, 13 | THROMBOGENICS NV |
| 8,460,656 | Phytase variants | Mar 19, 07 | Jun 11, 13 | NOVOZYMES A/S |
| 8,460,657 | Modulation of the TrpV: Vps10p receptor system for the treatment of pain | Jun 24, 09 | Jun 11, 13 | H. LUNDBECK A/S |
| 8,460,658 | Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same | Jun 13, 11 | Jun 11, 13 | ALCHEMIA ONCOLOGY PTY LIMITED |
| 8,460,659 | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases | Sep 12, 11 | Jun 11, 13 | JANSSEN BIOTECH, INC. |
| 8,460,660 | Anti-mesothelin antibodies | Mar 23, 10 | Jun 11, 13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION |
| 8,460,661 | Methods of using antibodies that bind the glutamate ligand binding region of Notch1 | Nov 30, 11 | Jun 11, 13 | ONCOMED PHARMACEUTICALS, INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2013/0149,236 | Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof | Mar 01, 11 | Jun 13, 13 | MACROGENICS, INC. |
| 2013/0149,237 | DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS | Jan 21, 11 | Jun 13, 13 | GENENTECH INC.; F. HOFFMANN - LA ROCHE AG; |
| 2013/0149,238 | Anti-VEGF Antibody Compositions and Methods | Feb 15, 13 | Jun 13, 13 | PEREGRINE PHARMACEUTICALS, INC.; AFFITECH RESEARCH AS; |
| 2013/0149,239 | 5-PYRROLIDINYLSULFONYL-ISATIN DERIVATIVES | Nov 26, 12 | Jun 13, 13 | UNIVERSITATSKLINIKUM MUNSTER |
| 2013/0149,240 | 99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS | Jan 30, 13 | Jun 13, 13 | Not available |
| 2013/0149,241 | PEPTIDE RADIOTRACER COMPOSITIONS | Aug 11, 11 | Jun 13, 13 | GE HEALTHCARE LIMITED |
| 2013/0149,242 | Labeled Alginate Conjugates for Molecular Imaging Applications | Dec 07, 12 | Jun 13, 13 | IKARIA DEVELOPMENT SUBSIDIARY ONE LLC |
| 2013/0149,243 | METHOD FOR PRODUCTION OF F-18 LABELED GLUTAMIC ACID DERIVATIVES | Nov 06, 10 | Jun 13, 13 | BAYER INTELLECTUAL PROPERTY GMBH |
| 2013/0149,244 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | May 11, 11 | Jun 13, 13 | LANTHEUS MEDICAL IMAGING, INC |
| 2013/0149,245 | Novel Peptides and Uses Thereof | Sep 20, 12 | Jun 13, 13 | CHILDREN'S HOSPITAL LOS ANGELES; ALFRED E. MANN INSTITUTE FOR BIOMEDICAL ENGINEERING AT THE UNIVERSITY OF SOUTHERN CALIFORNIA; |
| 2013/0149,247 | VIVO TUMOR TARGETING AND SPECTROSCOPIC DETECTION WITH SURFACE-ENHANCED RAMAN NANOPARTICLE TAGS | Nov 19, 12 | Jun 13, 13 | EMORY UNIVESITY |
| 2013/0149,249 | IMAGING TUBERCULOSIS WITH PYRAZINAMIDE CONTRAST AGENTS | Aug 22, 11 | Jun 13, 13 | GE HEALTHCARE LIMITED |
| 2013/0149,251 | OPTICAL SENSOR CONJUGATES FOR DETECTING REACTIVE OXYGEN AND/OR REACTIVE NITROGEN SPECIES IN VIVO | Jun 02, 11 | Jun 13, 13 | THE GENERAL HOSPITAL CORPORATION |
| 2013/0149,252 | SWITCHING FLUORESCENT NANOPARTICLE PROBE AND FLUORESCENT PARTICLE IMAGING METHOD USING SAME | Aug 08, 11 | Jun 13, 13 | Not available |
| 2013/0149,253 | ORAL DOSAGE FORM OF PREGABALIN | Aug 02, 11 | Jun 13, 13 | Not available |
| 2013/0149,254 | CHEWABLE POUCH FOR FLAVORED PRODUCT DELIVERY | Jan 29, 13 | Jun 13, 13 | PHILIP MORRIS USA INC. |
| 2013/0149,255 | VITAMIN B12 COMPOSITIONS | Feb 05, 13 | Jun 13, 13 | BEBAAS, INC. |
| 2013/0149,256 | Personal care and medicinal products incorporating orgnosulfur groups | Nov 16, 12 | Jun 13, 13 | Not available |
| 2013/0149,257 | ANTIMICROBIAL COMPOSITIONS | May 23, 11 | Jun 13, 13 | INDENA S. P. A. |
| 2013/0149,258 | RAPIDLY DISSOLVING COMESTIBLE SOLID | Dec 05, 12 | Jun 13, 13 | THE HERSHEY COMPANY |
